JP2009524606A - Method for the synthesis of acratonium napadisylate and its analogues - Google Patents

Method for the synthesis of acratonium napadisylate and its analogues Download PDF

Info

Publication number
JP2009524606A
JP2009524606A JP2008551635A JP2008551635A JP2009524606A JP 2009524606 A JP2009524606 A JP 2009524606A JP 2008551635 A JP2008551635 A JP 2008551635A JP 2008551635 A JP2008551635 A JP 2008551635A JP 2009524606 A JP2009524606 A JP 2009524606A
Authority
JP
Japan
Prior art keywords
compound
organic solvent
measures
carried out
esterification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008551635A
Other languages
Japanese (ja)
Other versions
JP5007309B2 (en
Inventor
徐自奥
李徳剛
劉宏亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2009524606A publication Critical patent/JP2009524606A/en
Application granted granted Critical
Publication of JP5007309B2 publication Critical patent/JP5007309B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/06Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton

Abstract

本発明は下式(V)化合物の合成方法について述べたものである。
【化1】

Figure 2009524606

そのうち、R1〜R7の相違はそれぞれ水素、C1〜4のアルキル基による。nは1〜4の整数から選んだ。特に“ワンポット合成法”を採用している。本発明は他にも乳酸を原料としてコリン類薬物アクラトニウムナパジシル酸塩及びその類似化合物の合成方法を提示している。この方法は原材料が得やすく、生産コストが比較的低く、同時に技術要求が低く、制御しやすく、大規模生産に向いている。The present invention describes a method for synthesizing the compound of the following formula (V).
[Chemical 1]
Figure 2009524606

Among them, hydrogen differences R1~R7 respectively, by an alkyl group of C 1 to 4. n was selected from an integer of 1 to 4. In particular, the “one-pot synthesis method” is adopted. The present invention also provides a method for synthesizing the cholinergic drug acratonium napadisylate and its similar compounds using lactic acid as a raw material. This method is easy to obtain raw materials, has a relatively low production cost, has low technical requirements, is easy to control, and is suitable for large-scale production.

Description

発明の詳細な説明Detailed Description of the Invention

[技術分野]
本発明は、下式(V)化合物の合成方法、特に“ワンポット合成”を採用した化合物Vの合成方法に関するものである。本発明は他に下式(I)のコリン類薬物活性化成分のアクラトニウムナパジシル酸塩及びその類似化合物の合成、特にアクラトニウムナパジシル酸塩の合成方法に関するもので、薬学化学分野に属する。
[Technical field]
The present invention relates to a method for synthesizing a compound of the following formula (V), particularly to a method for synthesizing a compound V employing “one-pot synthesis”. The present invention also relates to the synthesis of actinium napadisylate and its similar compounds, which are choline compounds activating components of the following formula (I), and in particular to a method for synthesizing acratonium napadisylate. Belonging to.

Figure 2009524606
Figure 2009524606

Figure 2009524606
この中でR1〜R8の相違はそれぞれ水素、C1〜4のアルキル基による。nは1〜4の整数から選んだ。
Figure 2009524606
Each in this difference in R1~R8 hydrogen, by an alkyl group of C 1 to 4. n was selected from an integer of 1 to 4.

[背景技術]
コリン類薬品活性化成分アクラトニウムナパジシル酸塩及びその類似化合物は、一種の平滑筋及び消化器運動機能増強薬で、胃腸及び胆管の興奮作用があり、胃幽門前庭部への作用は強く、消化器官のほかの部位への作用は胃より弱い。他にも、胆管末端の運動亢進、胆嚢内圧上昇、胆汁十二指腸排泄を促進することができる。迷走神経及びモルヒネによる運動機能低下状態に対しても増強作用があり、健常者だけでなく、慢性胃炎或いは術後患者に対しても胃内容物排出作用を促進することができる。消化器官機能異常、例えば悪心や嘔吐、食欲不振、腹部膨満感、慢性胃炎、胆管運動障害、消化器術後等の治療に使われる。現在、臨床で使用されている薬物は主にアクラトニウムナパジシル酸塩で、化学結合式は下記の通りである(Ia):
[Background technology]
Actinium napadisylate and its similar compounds, which are cholinergic chemical activation components, are a kind of smooth muscle and gastrointestinal motility enhancer, and have a gastrointestinal and bile duct excitability, and strong action on the gastropyloric antrum. The action on other parts of the digestive tract is weaker than that of the stomach. In addition, it is possible to promote increased bile duct movement, increased pressure in the gallbladder, and excretion of bile duodenum. It also has an enhancing effect on the state of motor function decline due to the vagus nerve and morphine, and can promote the gastric emptying action not only for healthy subjects but also for chronic gastritis or postoperative patients. It is used to treat gastrointestinal dysfunction, such as nausea and vomiting, loss of appetite, abdominal bloating, chronic gastritis, bile duct dysfunction, and post-digestive surgery. Currently, the drugs in clinical use are mainly acratonium napadisylate, and the chemical bonding formula is as follows (Ia):

Figure 2009524606
Figure 2009524606

[発明の開示]
[発明が解決しようとする課題]
現有のアクラトニウムナパジシル酸塩及び類似化合物の合成技術では、原料獲得、原料合成の難度が高い上に中間生成物の単離や精製が難しく、設備要求や生産コストも比較的高いため、大規模生産には向いていなかった。
[Disclosure of the Invention]
[Problems to be solved by the invention]
In the existing synthesis technology of acratonium napadisilate and similar compounds, it is difficult to acquire and synthesize raw materials, and it is difficult to isolate and purify intermediate products, and the equipment requirements and production costs are relatively high. It was not suitable for large-scale production.

本発明の主旨は大規模生産に適したアクラトニウムナパジシル酸塩と類似化合物の生産方法を提供することである。   The gist of the present invention is to provide a method for producing acratonium napadisilate and similar compounds suitable for large-scale production.

[課題を解決するための手段]
本発明の技術プロトコルは以下の通り:
本発明は化合物Vを生成する方法を提示する。化合物IIは以下の方法によって得ることができる:
(1)化合物IIと塩化アセチルaをエステル化し、化合物IIIを得る。
[Means for solving problems]
The technical protocol of the present invention is as follows:
The present invention presents a method of producing compound V. Compound II can be obtained by the following method:
(1) Compound II and acetyl chloride a are esterified to obtain compound III.

Figure 2009524606
(2)化合物IIIと塩化チオニル(SOCl)をアルキル化し、化合物IVを得る。
Figure 2009524606
(2) Compound III and thionyl chloride (SOCl 2 ) are alkylated to obtain compound IV.

Figure 2009524606
(3)合物IVとアルカミンbを有機溶剤と酸受容体とともにエステル化し、化合物Vを得る。
Figure 2009524606
(3) Compound IV and alkamine b are esterified together with an organic solvent and an acid acceptor to obtain compound V.

Figure 2009524606
この中でR1〜R7の違いはそれぞれ水素、C1〜4のアルキル基による。nは1〜4の整数から選んだ。
Figure 2009524606
Each in this difference in R1~R7 hydrogen, by an alkyl group of C 1 to 4. n was selected from an integer of 1 to 4.

本発明の優先プロトコルとして、上記の方法のように“ワンポット合成”によって、措置(1)〜(3)を同一の反応容器にて行うことである。   As a priority protocol of the present invention, measures (1) to (3) are performed in the same reaction vessel by “one-pot synthesis” as in the above method.

また、本発明は化合物Iの生成方法を提示する。化合物Iは化合物IIより以下の方法にて生成できる。
(1)化合物IIと塩化アセチルaをエステル化し化合物IIIを得る。
The present invention also presents a method for producing Compound I. Compound I can be produced from compound II by the following method.
(1) Compound II and acetyl chloride a are esterified to obtain compound III.

Figure 2009524606
(2)化合物IIIと塩化チオニル(SOCl)をアルキル化し、化合物IVを得る。
Figure 2009524606
(2) Compound III and thionyl chloride (SOCl 2 ) are alkylated to obtain compound IV.

Figure 2009524606
(3)化合物IVとアルカミンbを有機溶剤と酸受容体とともにエステル化し、化合物Vを得る。
Figure 2009524606
(3) Compound IV and alkamine b are esterified with an organic solvent and an acid acceptor to obtain compound V.

Figure 2009524606
(4)化合物Vと1、5−ナフタレンジスルホン酸デアルキル脂cを有機溶剤で反応させ、化合物Iを得る。
Figure 2009524606
(4) Compound V is reacted with 1,5-naphthalenedisulfonic acid dealkyl fat c in an organic solvent to obtain Compound I.

Figure 2009524606
この中でR1〜R8の相違はそれぞれ水素、C1〜4のアルキル基による。nは1〜4の整数から選んだ。
Figure 2009524606
Each in this difference in R1~R8 hydrogen, by an alkyl group of C 1 to 4. n was selected from an integer of 1 to 4.

本発明の優先プロトコルとして、上記の化合物Iの生成方法として“ワンポット合成”を採用し、措置(1)〜(3)は同一の反応容器にて行う。生成された化合物Vを更に1、5−ナフタレンジスルホン酸デアルキル脂cと反応させ化合物Iを得る。   As a priority protocol of the present invention, “one-pot synthesis” is adopted as a method for producing the above compound I, and measures (1) to (3) are carried out in the same reaction vessel. The resulting compound V is further reacted with 1,5-naphthalenedisulfonic acid dealkyl fat c to obtain compound I.

上記の方法のでは、措置(1)と(2)は溶剤がある状態でもない状態でも行うことができる。有機溶剤は非プロトン性溶媒、例えばベンジン、トルエンあるいはエーテル類溶剤(例えばジエチルエーテル)などのうち一種あるいは多種を優先的に使用する。また、本発明では措置(1)と(2)は溶媒がない状態で行うものとしている。   In the above method, the measures (1) and (2) can be performed with or without a solvent. As the organic solvent, one or more aprotic solvents such as benzine, toluene or ether solvents (for example, diethyl ether) are preferentially used. In the present invention, the measures (1) and (2) are performed in the absence of a solvent.

そして、措置(1)と(2)の反応時間と温度には、特別な要求はない。例えば、措置(1)のエステルかは通常0〜100℃で1〜8時間という条件で行い、措置(2)のアルキル化は通常20〜80℃で2〜6時間の条件で行う。   And there is no special requirement for the reaction time and temperature of measures (1) and (2). For example, the ester of the measure (1) is usually performed at 0 to 100 ° C. for 1 to 8 hours, and the alkylation of the measure (2) is usually performed at 20 to 80 ° C. for 2 to 6 hours.

上記の方法では、措置(3)の有機溶剤は、アセトニトリル、ジエチルエーテル、ベンジン、アセトン、クロロホルム等のうち一つか多数を使用する。また、縛酸剤としては第三級アミン、トリエチルアミン、N、N-ジメチルホルムアミド、ピリジンのうち一つか多数を使う。   In the above method, the organic solvent of the measure (3) uses one or many of acetonitrile, diethyl ether, benzine, acetone, chloroform and the like. In addition, as a binding acid agent, one or many of tertiary amine, triethylamine, N, N-dimethylformamide and pyridine are used.

また、措置(3)のエステル化では、優先的に−10〜30℃で0.5〜6時間行う。反応終了後に、純化、分離、乾燥と濃縮を行った後、比較的高純度の化合物Vを得ることができる。   Further, the esterification in the measure (3) is preferentially carried out at −10 to 30 ° C. for 0.5 to 6 hours. After completion of the reaction, purification, separation, drying and concentration are performed, and then a relatively high purity compound V can be obtained.

本発明の具体的な施行方法として、上記の方法の中でR1、R6、R7を水素、R2、R3、R4、R5、R8はアルキル基、nを2とし、化合物Iは下記結合式の化合物Iaである。   As a specific enforcement method of the present invention, among the above methods, R1, R6, R7 are hydrogen, R2, R3, R4, R5, R8 are alkyl groups, n is 2, and compound I is a compound of the following bond formula Ia.

Figure 2009524606
Figure 2009524606

[発明の効果]
現有のアクラトニウムナパジシル酸塩及びその類似化合物の合成技術と比べ、本発明の反応原料は廉価で入手しやすく、特に本発明のアクラトニウムナパジシル酸塩とその類似化合物の反応原料となる乳酸は原料が豊富の上、廉価で入手しやすい。本発明の最も突出している特徴は原材料(化合物II)から中間生成物(化合物V)の合成過程にある。“ワンポット合成”或いは“一釜法”によって行われ、すべての反応家庭を同一の反応容器で行うことができ、純化措置や反応設備を節約でき、収率を向上させ、生産コストを大幅に削減できる。また、本発明の合成方法の反応条件温度等は制御しやすく操作も容易で大規模な生産に向いている。
[The invention's effect]
Compared with the existing synthesizing technology of acratonium napadisylate and its similar compounds, the reaction raw material of the present invention is inexpensive and easy to obtain. Lactic acid is abundant in raw materials and is inexpensive and easy to obtain. The most prominent feature of the present invention lies in the process of synthesizing the intermediate product (Compound V) from the raw material (Compound II). Performed by “one pot synthesis” or “one pot method”, all reaction households can be carried out in the same reaction vessel, saving purification measures and reaction equipment, improving yields and greatly reducing production costs it can. Further, the reaction condition temperature of the synthesis method of the present invention is easy to control and easy to operate, and is suitable for large-scale production.

[発明を実施するための最良の形態]
以下の生成例を通して本発明の詳細な説明を行う。生成例は本発明の内容と主旨に限定されるものではない。
[Best Mode for Carrying Out the Invention]
The present invention will be described in detail through the following generation examples. The generation example is not limited to the contents and the gist of the present invention.

(生成例1):2−アセトキシメチルプロパノール(化合物Va)の生成   (Production Example 1): Production of 2-acetoxymethylpropanol (Compound Va)

Figure 2009524606
200g(90%)(2.0mol)の乳酸を反応容器に入れ、攪拌しながら282g(3.6mol)の塩化アセチルを滴定、滴定後20〜30℃で4時間反応させ、反応終了後反応液を減圧蒸留し、余剰の塩化アセチルを蒸発させる。蒸発後、α−アセトキシメチルを得る。357g(3.0mol)の塩化チオニルを滴定し、滴定後加熱し4時間反応させる。反応終了後、減圧蒸留によって余剰の塩化チオニルを蒸発させ、2−アセトキシメチルプロパノールクロライドを得る。冷却しながら134g(1.5mol)N、N−ジメチルアミノエタノール、152g(1.5mol)トリエチルアミンと1000mlのジエチルエーテルを上記の反応容器に加え、5〜10℃で2時間攪拌し、反応終了後濾過し、濾過液を1%NaOH溶液で洗浄する。有機層は無水硫酸ナトリウムで乾燥させ、濾過しジエチルエーテル層を蒸留した後、減圧蒸留し化合物Vaを得る(244g、収率60%)。
Figure 2009524606
200 g (90%) (2.0 mol) of lactic acid was put into a reaction vessel, and 282 g (3.6 mol) of acetyl chloride was titrated with stirring and reacted at 20-30 ° C. for 4 hours after the titration. Is distilled under reduced pressure to evaporate excess acetyl chloride. After evaporation, α-acetoxymethyl is obtained. 357 g (3.0 mol) of thionyl chloride is titrated and heated after the titration for 4 hours. After completion of the reaction, excess thionyl chloride is evaporated by distillation under reduced pressure to obtain 2-acetoxymethylpropanol chloride. While cooling, 134 g (1.5 mol) N, N-dimethylaminoethanol, 152 g (1.5 mol) triethylamine and 1000 ml diethyl ether were added to the above reaction vessel and stirred at 5-10 ° C. for 2 hours. Filter and wash the filtrate with 1% NaOH solution. The organic layer is dried over anhydrous sodium sulfate, filtered, and the diethyl ether layer is distilled, followed by distillation under reduced pressure to obtain Compound Va (244 g, yield 60%).

(生成例2):2アセトキシメチルプロパノール(化合物Va)の生成
200g(90%)(2.0mol)の乳酸を反応容器に入れ、攪拌しながら塩化アセチル282g(3.6mol)を滴定し、20〜30℃で4時間反応させ、反応終了後反応液を減圧蒸留し、余剰の塩化アセチルを蒸発させる。蒸留後α−アセトキシメチルを得る。357g(3.0mol)の塩化チオニルを滴定し、加熱回流で4時間反応させた後、減圧蒸留で余剰の塩化チオニルを蒸発させ、2−アセトキシメチルプロパノールクロライドを得る。冷却しつつ134g(1.5mol)のN、N-ジメチルアミノエタノール、110g(1.5mol)ジメチルホルムアミドと1000mlのベンジンを上記の反応容器に入れ、5〜10℃で攪拌しつつ2時間反応させ、濾過し、濾過液を%NaOH溶液で洗浄する。有機層は無水硫酸ナトリウムで乾燥、濾過しベンジン層を蒸留したのち、減圧蒸留し化合物Vaを得る(236g、収率58.1%)。
(Production Example 2): Production of 2 acetoxymethylpropanol (Compound Va) 200 g (90%) (2.0 mol) of lactic acid was placed in a reaction vessel, and 282 g (3.6 mol) of acetyl chloride was titrated while stirring. The reaction is carried out at -30 ° C for 4 hours, and after completion of the reaction, the reaction solution is distilled under reduced pressure to evaporate excess acetyl chloride. Α-Acetoxymethyl is obtained after distillation. 357 g (3.0 mol) of thionyl chloride is titrated and reacted for 4 hours by heating circulation, and then excess thionyl chloride is evaporated by distillation under reduced pressure to obtain 2-acetoxymethylpropanol chloride. While cooling, 134 g (1.5 mol) of N, N-dimethylaminoethanol, 110 g (1.5 mol) of dimethylformamide and 1000 ml of benzine were placed in the above reaction vessel and allowed to react for 2 hours while stirring at 5 to 10 ° C. Filter and wash the filtrate with% NaOH solution. The organic layer is dried over anhydrous sodium sulfate and filtered, and the benzine layer is distilled, followed by distillation under reduced pressure to obtain Compound Va (236 g, yield 58.1%).

(生成例3):2−アセトキシメチルプロパノール(化合物Va)の生成
生成例1と同様の方法を行い、その中で119g(1.5mol)ピリジン、1000mlクロロホルムをそれぞれ生成例1のトリエチルアミン、ジエチルエーテルと置き換え、化合物Vaを得る(229g、収率56.3%)。
(Production Example 3): Production of 2-acetoxymethylpropanol (Compound Va) The same method as in Production Example 1 was performed, in which 119 g (1.5 mol) pyridine and 1000 ml chloroform were produced, respectively. Triethylamine and diethyl ether of Production Example 1 To give compound Va (229 g, 56.3% yield).

(生成例4)アクラトニウムナパジシル酸塩(化合物Ia)の生成
100g(0.316mol)の1,5−ジメチルナパジシル酸塩と800mlのイソプロピルアルコールを反応容器に入れ、攪拌しつつ130g(0.634mol)の2−アセトキシメチルプロパノール(化合物Va)を加え、50〜60℃まで加熱し1時間攪拌し、反応終了後熱を取り、濾過し170gのアクラトニウムナパジシル酸塩(化合物Ia)を得る。収率74.5%、融点191〜192℃。構造(C304614)、理論値(%)C49.85,H6.42,N3.88;実測値(%)C49.84,H6.44,N3.88;1H−NMR(DO):1.350(3H,d,CHCH), 2.046(3H,s,COCH),3.011(3H,s,NCH),3.547(2H,t,NCHCH),4.412(2H,t,NCHCH),4.976(1H,q,CHCH),7.675〜8.798(Ar−H)。13C−NMR(D2O):15.865(CHCH),20.101(COCH),53.750(NCH),59.258(NCHCH),64.397(NCHCH),69.448(CHCH),
126.348〜139.251(−C=),172.025(OCOCHCH),173.440(OCOCH)。IR(cm−1): 3036,2984,1758,1733,1491,1456,1380,1247,1201,1106,1033,803。MS(EI)m/z:222,127,115,58,42。
(Production Example 4) Production of acratonium napadisylate (Compound Ia) 100 g (0.316 mol) of 1,5-dimethylnapadisylate and 800 ml of isopropyl alcohol were placed in a reaction vessel and stirred while stirring 130 g. (0.634 mol) of 2-acetoxymethylpropanol (Compound Va) was added, heated to 50-60 ° C. and stirred for 1 hour. After completion of the reaction, the heat was removed, filtered, and 170 g of akratonium napadisylate (compound) Ia) is obtained. Yield 74.5%, mp 191-192 ° C. Structure (C 30 H 46 N 2 O 14 S 2), the theoretical value (%) C49.85, H6.42, N3.88 ; Found (%) C49.84, H6.44, N3.88 ; 1 H -NMR (D 2 O): 1.350 (3H, d, CHCH 3), 2.046 (3H, s, COCH 3), 3.011 (3H, s, NCH 3), 3.547 (2H, t, NCH 2 CH 2), 4.412 (2H, t, NCH 2 CH 2), 4.976 (1H, q, CHCH 3), 7.675~8.798 (Ar-H). 13C-NMR (D2O): 15.865 (CHCH 3), 20.101 (COCH 3), 53.750 (NCH 3), 59.258 (NCH 2 CH 2), 64.397 (NCH 2 CH 2) , 69.448 (CHCH 3 ),
126.348~139.251 (-C =), 172.025 ( OCOCHCH 3), 173.440 (OCOCH 3). IR (cm-1): 3036, 2984, 1758, 1733, 1491, 1456, 1380, 1247, 1201, 1106, 1033, 803. MS (EI) m / z: 222, 127, 115, 58, 42.

(生成例5)アクラトニウムナパジシル酸塩(化合物Ia)の生成
100g(0.316mol)1,5−メチルナパジシル酸塩と900mlアセトンを反応容器に入れ、攪拌しつつ130g(0.634mol)2−アセトキシメチルプロパノール(化合物Va)を入れ、50〜60℃まで加熱し、1時間攪拌した後、熱を取って濾過し、167gのアクラトニウムナパジシル酸塩(化合物Ia)を得る。収率73.1%、融点191〜192℃。
(Production Example 5) Production of akratonium napadisylate (Compound Ia) 100 g (0.316 mol) 1,5-methylnapadisylate and 900 ml acetone were placed in a reaction vessel and stirred with 130 g (0.634 mol) 2 -Acetoxymethylpropanol (Compound Va) is added, heated to 50-60 ° C, stirred for 1 hour, then filtered by taking heat to obtain 167 g of Acratonium napadisylate (Compound Ia). Yield 73.1%, mp 191-192 ° C.

(生成例6):2−アセトプロピルプロパノール(化合物Vb)の生成
200g(90%)(2.0mol)の乳酸を反応容器に入れ、攪拌しつつ332.8g(3.6mol)のプロピオン酸クロライドを滴定した後、20〜30℃で4時間反応させる。反応後減圧蒸留し、余剰のプロピオン酸クロライドを蒸発させ、α−アセトプロピルを得る。357g(3.0mol)塩化チオニルを滴定した後、加熱回流で4時間反応させた後、余剰な塩化チオニルを蒸発させ、2−アセトプロピオン酸クロライドを得る。冷却しつつ134g(1.5mol)N,N-ジメチルアミノエタノール、152g(1.5mol)トリエチルアミンと1000mlジエチルエーテルを上記の反応容器に加え、5〜10℃で2時間反応させた後、濾過し、濾過液を1%NaOH溶液で洗浄する。有機層は無水硫酸ナトリウムで乾燥、濾過しジエチルエーテル層を蒸留した後、減圧蒸留し、化合物Vbを得る(265g、収率61.0%)。
(Production Example 6): Production of 2-acetopropylpropanol (Compound Vb) 200 g (90%) (2.0 mol) of lactic acid was placed in a reaction vessel and stirred with 332.8 g (3.6 mol) of propionic acid chloride. Is allowed to react at 20-30 ° C. for 4 hours. After the reaction, the reaction mixture is distilled under reduced pressure to evaporate excess propionic acid chloride to obtain α-acetopropyl. After titration of 357 g (3.0 mol) thionyl chloride, the reaction was carried out for 4 hours by heating circulation, and then excess thionyl chloride was evaporated to obtain 2-acetopropionic acid chloride. While cooling, 134 g (1.5 mol) N, N-dimethylaminoethanol, 152 g (1.5 mol) triethylamine and 1000 ml diethyl ether were added to the above reaction vessel, reacted at 5 to 10 ° C. for 2 hours, and then filtered. The filtrate is washed with 1% NaOH solution. The organic layer is dried over anhydrous sodium sulfate and filtered, and the diethyl ether layer is distilled, followed by distillation under reduced pressure to obtain compound Vb (265 g, yield 61.0%).

(生成例7):マロトニウムナパジシル酸塩(化合物Ib)の生成
100g(0.316mol)1,5−ジメチルナパジシル酸塩と800mlイソプロピルアルコールを反応容器に入れ、攪拌しつつ138g(0.634mol)2−アセトプロピルプロパノール(化合物Vb)を加え、50〜60℃まで加熱し1時間攪拌後、熱を取り、176gのマロトニウムナパジシル酸塩(化合物Ib)を得る。収率:75.6%、融点120〜122℃。構造(C314814)、理論値(%):C50.53,H6.57,N3.80、実測値(%):C50.46,H6.49,N3.72。
(Production Example 7): Production of malotonium napadisylate (Compound Ib) 100 g (0.316 mol) 1,5-dimethylnapadisylate and 800 ml isopropyl alcohol were placed in a reaction vessel and stirred with 138 g ( 0.634 mol) 2-acetopropylpropanol (Compound Vb) is added, heated to 50-60 ° C., stirred for 1 hour, and then heated to obtain 176 g of malotonium napadisylate (Compound Ib). Yield: 75.6%, melting point 120-122 ° C. Structure (C 31 H 48 N 2 O 14 S 2), the theoretical value (%): C50.53, H6.57, N3.80, Found (%): C50.46, H6.49, N3.72.

(生成例8):ブチトニウムナパジシル酸塩(化合物Ic)の生成
上記の生成方法例における塩化アセチル或いはプロピオン酸クロライドをブチリルクロリドに置き換え、ブチトニウムナパジシル酸塩(化合物Ic)を得る。
(Production Example 8): Production of Butynium Napadisylate (Compound Ic) Acetyl chloride or propionic acid chloride in the above production method example was replaced with butyryl chloride, and butytonium napadisylate (Compound Ic) was replaced. obtain.

生成例を用いて本発明を詳しく説明した。上記の描写と実施例は本発明の例に過ぎない。本発明の目的と範囲の中で、本領域技術者は本発明の代行プロトコルや改善プロトコルを設計することができ、本発明の保護範囲内にそれらは属する。   The present invention has been described in detail using generation examples. The above depictions and examples are merely examples of the invention. Within the purpose and scope of the present invention, a domain engineer can design proxy protocols and improved protocols of the present invention, which fall within the protection scope of the present invention.

Claims (10)

化合物Vの生成方法の特徴は化合物IIを以下の措置によって得ることである:
(1)化合物IIと塩化アセチルaによるエステル化反応によって化合物IIIを得る。
Figure 2009524606
(2)化合物IIIと塩化チオニル(SOCl)によるアルキル化反応によって化合物IVを得る。
Figure 2009524606
(3)有機溶剤と酸受容体の中で化合物IVとアルカミンbのエステル化反応によって化合物Vを得る。
Figure 2009524606
この中でR1〜R7の相違はそれぞれ水素、C1〜4のアルキル基による。nは1〜4の整数から選んだ。
A feature of the method of producing compound V is that compound II is obtained by the following measures:
(1) Compound III is obtained by esterification reaction between Compound II and acetyl chloride a.
Figure 2009524606
(2) Compound IV is obtained by an alkylation reaction between compound III and thionyl chloride (SOCl 2 ).
Figure 2009524606
(3) Compound V is obtained by esterification of compound IV and alkamine b in an organic solvent and an acid acceptor.
Figure 2009524606
Each in this difference in R1~R7 hydrogen, by an alkyl group of C 1 to 4. n was selected from an integer of 1 to 4.
請求項1に述べた方法に基づき、述べた方法は“ワンポット合成”法にて行われることが特徴である。措置(1)〜(3)は同一の反応容器内で行われる。   Based on the method described in claim 1, the method described is characterized in that it is carried out by the “one-pot synthesis” method. Measures (1) to (3) are performed in the same reaction vessel. 化合物Iの生成方法の特徴は、以下の措置により化合物IIから生成される:
(1)化合物IIと塩化アセチルaのエステル化反応により、化合物IIIを得る。
Figure 2009524606
(2)化合物IIIと塩化チオニル(SOCl)によるアルキル化により、化合物IVを得る。
Figure 2009524606
(3)有機溶剤と酸受容体の中で化合物IVとアルカミンbのエステル化反応によって化合物Vを得る。
Figure 2009524606
(4)有機溶剤の中で化合物Vと1,5−ナフタレンジスルホン酸デアルキル脂cを反応させ、化合物Iを得る。
Figure 2009524606
この中でR1〜R8の相違はそれぞれ水素、C1〜4のアルキル基による。nは1〜4の整数から選んだ。
A feature of the method of producing Compound I is produced from Compound II by the following measures:
(1) Compound III is obtained by esterification of compound II and acetyl chloride a.
Figure 2009524606
(2) Alkylation with compound III and thionyl chloride (SOCl 2 ) provides compound IV.
Figure 2009524606
(3) Compound V is obtained by esterification of compound IV and alkamine b in an organic solvent and an acid acceptor.
Figure 2009524606
(4) Compound V is reacted with 1,5-naphthalenedisulfonic acid dealkyl fat c in an organic solvent to obtain Compound I.
Figure 2009524606
Each in this difference in R1~R8 hydrogen, by an alkyl group of C 1 to 4. n was selected from an integer of 1 to 4.
請求項3にて述べた方法に基づき、この方法は“一釜法”にて行われ、措置(1)〜(3)は同一の容器内にて行われる。   Based on the method described in claim 3, this method is carried out by the “one pot method”, and measures (1) to (3) are carried out in the same container. 請求項1〜4の方法に基づき、その措置(1)と(2)は溶剤或いは有機溶剤がない状態で行う。優先的に溶剤がない状態で行う。   Based on the method of claims 1 to 4, the measures (1) and (2) are carried out in the absence of solvent or organic solvent. Priority is given to the absence of solvent. 請求項5の方法に基づき、有機溶剤は優先的に非極性溶剤のベンジン、トルエン、エーテル類溶剤(例えばジエチルエーテル)のうち一種か多種を使用する。   Based on the method of claim 5, one or more of the non-polar solvents benzine, toluene and ether solvents (for example, diethyl ether) are preferentially used as the organic solvent. 請求項1〜6の方法に基づき、措置(3)で述べた有機溶剤は優先的にアセトニトリル、ジエチルエーテル、ベンジン、アセトン、クロロホルムのうち、一種か多種を使用する。   Based on the method of claims 1 to 6, the organic solvent described in the measure (3) is preferentially used in the form of one or more of acetonitrile, diethyl ether, benzine, acetone and chloroform. 請求項1〜7の方法に基づき、措置(3)における酸受容体は優先的に、第三級アミン、例えばトリエチルアミン、N,N−ジメチルホルムアミド、N,N−ジメチルアセトアミド、ピリジン等から一種か多種を使用する。   Based on the method of claims 1-7, the acid acceptor in step (3) is preferentially one of tertiary amines such as triethylamine, N, N-dimethylformamide, N, N-dimethylacetamide, pyridine and the like. Use a variety. 請求項1〜8の方法に基づき、措置(4)で述べた有機溶剤は優先的にエタノール、イソプロピルアルコール、アセトニトリル、ジエチルエーテル、アセトン、ベンジン、トルエンのうち一種或いは多種を使用する。   Based on the method of Claims 1-8, the organic solvent described in the measure (4) is preferentially used one or more of ethanol, isopropyl alcohol, acetonitrile, diethyl ether, acetone, benzine and toluene. 請求項1〜9の方法に基づき、R1、R6、R7を水素、R2、R3、R4、R5、R8はアルキル基、nは2とする。   Based on the method of Claims 1-9, R1, R6 and R7 are hydrogen, R2, R3, R4, R5 and R8 are alkyl groups, and n is 2.
JP2008551635A 2006-11-24 2007-10-24 Method for the synthesis of acratonium napadisylate and its analogues Expired - Fee Related JP5007309B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNB2006101456958A CN100475773C (en) 2006-11-24 2006-11-24 Synthesis method of naphthalene disulfonic acid aclatonium and similar compound thereof
CN200610145695.8 2006-11-24
PCT/CN2007/070948 WO2008061466A1 (en) 2006-11-24 2007-10-24 Synthetic methods of aclatonium napadisilate and analogs thereof

Publications (2)

Publication Number Publication Date
JP2009524606A true JP2009524606A (en) 2009-07-02
JP5007309B2 JP5007309B2 (en) 2012-08-22

Family

ID=38017914

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008551635A Expired - Fee Related JP5007309B2 (en) 2006-11-24 2007-10-24 Method for the synthesis of acratonium napadisylate and its analogues

Country Status (3)

Country Link
JP (1) JP5007309B2 (en)
CN (1) CN100475773C (en)
WO (1) WO2008061466A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100475773C (en) * 2006-11-24 2009-04-08 李晓祥 Synthesis method of naphthalene disulfonic acid aclatonium and similar compound thereof
CN110386878B (en) * 2018-04-20 2022-04-22 扬子江药业集团有限公司 Industrial preparation method of diethyl cholamine napadisylate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5018413A (en) * 1973-06-20 1975-02-26
JPH01104085A (en) * 1987-07-15 1989-04-21 Zambon Group Spa Phosphonic acid derivative and enanthioselective manufacture

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5414092B1 (en) * 1970-12-28 1979-06-05
DE2425983C3 (en) * 1973-06-12 1978-09-14 Toyama Chemical Co. Ltd., Tokio Sulphonic acid salts of acylcholines, processes for their preparation and pharmaceutical compositions containing them
DE2546845A1 (en) * 1975-10-18 1977-04-28 Basf Ag Herbicidal (iso)quinolyloxy-alkanoic acid derivs. - prepd. e.g. by reacting hydroxy-(iso)quinoline cpds. with halo-alkanamides
JPS58180463A (en) * 1982-04-19 1983-10-21 Toyama Chem Co Ltd Preparation of bischolinedisulfonate
CN100475773C (en) * 2006-11-24 2009-04-08 李晓祥 Synthesis method of naphthalene disulfonic acid aclatonium and similar compound thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5018413A (en) * 1973-06-20 1975-02-26
JPH01104085A (en) * 1987-07-15 1989-04-21 Zambon Group Spa Phosphonic acid derivative and enanthioselective manufacture

Also Published As

Publication number Publication date
CN100475773C (en) 2009-04-08
CN1948271A (en) 2007-04-18
WO2008061466A1 (en) 2008-05-29
JP5007309B2 (en) 2012-08-22

Similar Documents

Publication Publication Date Title
UA101956C2 (en) Process and intermediates for the preparation of integrase inhibitors
DK159680B (en) CYCLIC IMIDES USED FOR THE PREPARATION OF CYCLIC AMINO ACIDS
WO2008092405A1 (en) Method for synthesizing 1,2,3-tri-o-acetyl-5-deoxy-d-ribose
WO2017096996A1 (en) Preparation method for cobimetinib
TW201920154A (en) Process for preparing lifitegrast and intermediates thereof
CN110590635A (en) Preparation method of levetiracetam and intermediate thereof
CN100591649C (en) Method of preparing R-(+)-3-chlorophenylpropanol
JP5007309B2 (en) Method for the synthesis of acratonium napadisylate and its analogues
CN103827082B (en) A kind of novel process preparing Peramivir and intermediate thereof
WO2009094847A1 (en) A capecitabine hydroxyl-derivative, its preparation processes and uses for preparing capecitabine
JP2018528233A (en) Process for producing indoline compounds and novel indoline salts
JP6248202B2 (en) Method for producing silodosin and its intermediate
CN106543018A (en) The method for preparing scheme for lacosamide
CN108033990A (en) The preparation method of Dexamethasone Intermediate
TWI613194B (en) A novel process for preparing enzalutamide
JP2012524044A (en) Process for the preparation of 2,4,6-octatrien-1-acid and 2,4,6-octatrien-1-ol
JPH01500522A (en) 2,3-diaminoacrylonitrile derivative
US2519530A (en) Biotin aliphatic amides and method for their preparation
WO2016145997A1 (en) Pharmaceutically active sugar molecule and synthesis method thereof
WO2016020403A1 (en) Preparation of a benzoic acid derivative and its use for the preparation of suvorexant
CN112272665A (en) Process for preparing sitagliptin
TWI835325B (en) Preparation method of (S)-4-chloro-2-aminobutyric acid hydrochloride and (S)-4-chloro-2-aminobutyric acid ester
CN112679457B (en) Process for the preparation of benzamide derivatives and their use
CN113024521B (en) Method for preparing emtrictinib
CN111087433B (en) Preparation method of tulathromycin intermediate

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111122

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120201

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120321

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120410

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120515

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120528

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150601

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees